Ovoca Bio plc
OVB.L · LSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | £1,795 | £847 | £780 | £5,694 |
| - Cash | £2,506 | £2,925 | £3,337 | £2,800 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£711 | -£2,078 | -£2,557 | £2,894 |
| Revenue | – | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | – | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | – | -£1,091 | £1,686 | -£2,235 |
| % Margin | – | – | – | – |
| Net Income | – | -£1,244 | -£3,515 | -£1,186 |
| % Margin | – | – | – | – |
| EPS Diluted | – | -0.013 | -0.048 | -0.015 |
| % Growth | – | 72.1% | -228.8% | – |
| Operating Cash Flow | £0 | -£1 | – | -£340 |
| Capital Expenditures | £0 | £0 | – | £0 |
| Free Cash Flow | £0 | -£1 | – | -£340 |